Sanofi (SNYNF)
OTC: SNYNF
· Real-Time Price · USD
101.18
0.13 (0.13%)
At close: Aug 18, 2025, 2:31 PM
Sanofi Income Statement
Financials in EUR. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 10.73B | 10.61B | 7.63B | 14.16B | 21.21B | 11.12B | 22.88B | 12.7B | 10.68B | 10.86B | 11.46B | 13.14B | 10.74B | 10.05B | 10.41B | 10.83B | 9.04B | 8.89B |
Cost of Revenue | 2.99B | 2.89B | 2.27B | 4.08B | 7.93B | 3.44B | 9.06B | 3.84B | 3.27B | 3.08B | 3.73B | 3.83B | 3.25B | 2.88B | 3.48B | 3.24B | 2.86B | 2.68B |
Gross Profit | 7.74B | 7.72B | 5.36B | 10.07B | 13.28B | 7.68B | 13.82B | 8.86B | 7.41B | 7.78B | 7.72B | 9.31B | 7.49B | 7.17B | 6.94B | 7.59B | 6.19B | 6.2B |
Operating Income | 1.47B | 2.29B | 1.19B | 3.63B | 4.6B | 1.45B | 4.78B | 3.21B | 1.86B | 2.46B | 1.95B | 2.72B | 1.43B | 2.4B | 1.47B | 3.04B | 1.55B | 2.06B |
Interest Income | 76M | 86M | 37M | 133M | 92M | 151M | 285M | 143M | 125M | 161M | 155M | 52M | 24M | 10M | 10M | 2M | 16M | 14M |
Pretax Income | 1.42B | 2.2B | 1.07B | 3.58B | 2.74B | 1.35B | 2.92B | 3.04B | 1.78B | 2.46B | 1.92B | 2.67B | 1.35B | 2.32B | 1.39B | 2.96B | 1.48B | 1.97B |
Net Income | 3.94B | 1.87B | 499M | 2.81B | 2.25B | 1.13B | 1.97B | 2.52B | 1.44B | 2B | 1.46B | 2.08B | 1.18B | 2.01B | 1.13B | 2.32B | 1.21B | 1.57B |
Selling & General & Admin | 2.63B | 2.22B | 1.24B | 2.68B | 5.26B | 2.6B | 5.51B | 2.58B | 2.58B | 2.61B | 2.9B | 2.64B | 2.57B | 2.38B | 2.76B | 2.27B | 2.34B | 2.19B |
Research & Development | 1.91B | 1.81B | 2.12B | 1.85B | 3.42B | 1.72B | 3.54B | 1.66B | 1.63B | 1.56B | 1.82B | 1.74B | 1.66B | 1.49B | 1.58B | 1.44B | 1.4B | 1.27B |
Other Expenses | 1.73B | 1.4B | 1.43B | 1.9B | n/a | -79M | n/a | n/a | n/a | -88M | -233M | 5M | -124M | -18M | -1M | -4M | n/a | n/a |
Operating Expenses | 6.27B | 5.43B | 4.79B | 6.44B | 8.68B | 5.45B | 9.04B | 5.4B | 5.25B | 4.96B | 5.36B | 4.66B | 5.22B | 4.58B | 5.12B | 4.38B | 4.32B | 3.95B |
Interest Expense | 87M | 213M | 96M | 265M | 135M | 253M | 313M | 318M | 202M | 168M | 180M | 103M | 101M | 88M | 93M | 87M | 112M | 99M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 9.26B | 8.32B | 7.06B | 10.52B | 16.61B | 8.89B | 18.11B | 9.24B | 8.52B | 8.04B | 9.09B | 8.49B | 8.47B | 7.46B | 8.59B | 7.62B | 7.17B | 6.63B |
Income Tax Expense | 230M | 481M | 190M | 737M | 463M | 164M | 872M | 563M | 271M | 459M | 407M | 601M | 163M | 332M | 268M | 609M | 278M | 404M |
Shares Outstanding (Basic) | 1.23B | 1.23B | 1.25B | 1.25B | 1.25B | 1.25B | 1.25B | 1.25B | 1.25B | 1.25B | 1.25B | 1.25B | 1.25B | 1.25B | 1.25B | 1.25B | 1.25B | 1.25B |
Shares Outstanding (Diluted) | 1.23B | 1.23B | 1.25B | 1.25B | 1.25B | 1.25B | 1.26B | 1.25B | 1.25B | 1.25B | 1.26B | 1.25B | 1.25B | 1.25B | 1.25B | 1.25B | 1.26B | 1.25B |
EPS (Basic) | 3.19 | 1.52 | 0.40 | 2.25 | 1.80 | 0.91 | 1.57 | 2.01 | 2.74 | 1.60 | 1.17 | 1.66 | 0.94 | 1.61 | 0.90 | 1.84 | 2.22 | 1.25 |
EPS (Diluted) | 3.19 | 1.52 | 0.40 | 2.25 | 1.79 | 0.91 | 1.56 | 2.01 | 2.73 | 1.60 | 1.16 | 1.66 | 0.94 | 1.61 | 0.90 | 1.84 | 2.21 | 1.25 |
EBITDA | 1.89B | 2.77B | 563M | 4.25B | 2.03B | 2.16B | 1.64B | 3.92B | 2.48B | 3.11B | 2.71B | 3.46B | 2.64B | 2.86B | 1.94B | 3.59B | 2.29B | 2.46B |
EBIT | 1.51B | 2.37B | 354M | 3.77B | 1.53B | 1.6B | -150M | 3.35B | 1.93B | 2.62B | 4.25B | 2.78B | 1.46B | 2.41B | 1.52B | 3.03B | 1.59B | 2.07B |
Depreciation & Amortization | 378M | 399M | 209M | 479M | 1.46B | 562M | 2.99B | 562M | 1.86B | 489M | 1.61B | 460M | 1.83B | 449M | 1.63B | 385M | 1.73B | 389M |